Evidence map›Paper›PMID 20024313›Full record

ArticleChemical communications (Cambridge, England)2010

Shell crosslinked nanoparticles carrying silver antimicrobials as therapeutics.

Yali Li, Khadijah Hindi, Kristin M Watts, Jane B Taylor, Ke Zhang, Zicheng Li, David A Hunstad, Carolyn L Cannon, Wiley J Youngs, Karen L Wooley

Abstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Anti-tumor activity of lipophilic imidazolium salts on select NSCLC cell lines.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2015
    Article
  6. Article
  7. Article
  8. Article
  9. Cationic antimicrobial polymers and their assemblies.International journal of molecular sciences · 2013
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yali LiDepartment of Chemistry and Radiology, Washington University, St Louis, MO 63130-4899, USA.
Khadijah Hindi
Kristin M Watts
Jane B Taylor
Ke Zhang
Zicheng Li
David A Hunstad
Carolyn L Cannon
Wiley J Youngs
Karen L Wooley

Funding

SYNTHESIS COMPONENTU01HL080729 · NHLBI · WASHINGTON UNIVERSITY · PI WOOLEY, KAREN L. · 2005 to 2009
$12.1M
Collaborative Research: Polymeric Drug Delivery Systems and Biofilms in the LungR01GM086895 · NIGMS · UNIVERSITY OF AKRON · PI YOUNG, GERALD W · 2008 to 2011
$1.5M
Silver carbene complexes as treatment of CF lung diseaseR01AI067856 · NIAID · WASHINGTON UNIVERSITY · PI CANNON, CAROLYN LOUISE · 2006 to 2008
$1.1M
Host Responses to E. Coli Urinary Tract InfectionK08DK067894 · NIDDK · WASHINGTON UNIVERSITY · PI HUNSTAD, DAVID · 2004 to 2008
$629k
NHLBI NIH HHS HL080729NHLBI NIH HHS U01 HL080729NIAID NIH HHS AI067856NIAID NIH HHS R01 AI067856NIDDK NIH HHS DK067894NIDDK NIH HHS K08 DK067894NIGMS NIH HHS GM086895NIGMS NIH HHS R01 GM086895
6 · The paper itself

Abstract

Amphiphilic polymer nanoparticles loaded with silver cations or/and N-heterocyclic carbene-silver complexes were assessed as antimicrobial agents against Gram-negative pathogens Escherichia coli and Pseudomonas aeruginosa.

Indexed as

Anti-Infective AgentsCross-Linking ReagentsEscherichia coliHeterocyclic CompoundsMethaneMicrobial Sensitivity TestsNanoparticlesPseudomonas aeruginosaSilverAnti-Infective AgentscarbeneCross-Linking ReagentsHeterocyclic CompoundsMethaneSilver

Identifiers

PMID20024313
PMCPMC2978063

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.